-+ 0.00%
-+ 0.00%
-+ 0.00%

Sedana Medical says FDA sets April 16, 2027 PDUFA date for isoflurane sedation NDA

PUBT·08/31/2026 05:35:27
Listen to the news
Sedana Medical says FDA sets April 16, 2027 PDUFA date for isoflurane sedation NDA
  • FDA set an April 16, 2027 PDUFA target date for reviewing Sedana Medical’s U.S. NDA for ICU inhaled sedation therapy.
  • NDA covers isoflurane delivered via the Sedana Medical ACD Delivery System for sedating mechanically ventilated adult ICU patients.
  • Approval would make it the first FDA-cleared inhaled sedation option for mechanically ventilated ICU patients in the U.S.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sedana Medical AB published the original content used to generate this news brief on August 31, 2026, and is solely responsible for the information contained therein.